2015
DOI: 10.1016/j.mito.2015.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Lon protease controls ROS-dependent apoptosis in cardiomyocyte under hypoxia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
43
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(44 citation statements)
references
References 35 publications
1
43
0
Order By: Relevance
“…Cardiomyocyte apoptosis induced by I/R is an essential process in the progression of heart failure. Mitochondria play a crucial role in cardiomyocyte apoptosis under hypoxic conditions [3,4]. This study showed that H/R treatment caused mitochondrial dysfunction and cardiomyocyte apoptosis, whereas, pretreatment with geniposide improved mitochondrial dysfunction and attenuated mitochondria-dependent cell apoptosis.…”
Section: Discussionmentioning
confidence: 75%
See 3 more Smart Citations
“…Cardiomyocyte apoptosis induced by I/R is an essential process in the progression of heart failure. Mitochondria play a crucial role in cardiomyocyte apoptosis under hypoxic conditions [3,4]. This study showed that H/R treatment caused mitochondrial dysfunction and cardiomyocyte apoptosis, whereas, pretreatment with geniposide improved mitochondrial dysfunction and attenuated mitochondria-dependent cell apoptosis.…”
Section: Discussionmentioning
confidence: 75%
“…ROS and RNS are products of mitochondrial oxidative stress, and production of ROS is a vital step in the mitochondria-dependent apoptosis pathway [3,4,27]. Physiological levels of ROS/RNS in normal oxidative metabolism play a key homeostatic role in balancing disposal rates of oxidative pressure and enzyme systems in cell proliferation and survival [27][28][29].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Although our prior studies proved that TXL had infarct-sparing effect during I/R in animals, it remained unclear whether TXL could protect human cardiomyocytes from reperfusion injury. As a consequence, for our in vitro experiments, we used human cardiomyocytes, which are widely employed in cardiovascular research (Albrecht-Schgoer et al, 2012;Boon et al, 2013;Baker et al, 2015;Kuo et al, 2015;Nehra et al, 2015;Sharma et al, 2015), rather than cardiomyocytes isolated from animals.…”
Section: Discussionmentioning
confidence: 99%